Expanded Hemodialysis Versus Online Hemodiafiltration
NCT03274518 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2019-09-30
Summary
Conventional hemodialysis (HD) is essential for the treatment of end-stage renal disease (ESRD) patients, by reducing serum concentration of uremic toxins and correcting fluid overload.
Nevertheless, HD removes almost exclusively low-range uremic toxins. Therefore, medium-range molecules, such as beta-2-microglobulin might accumulate in tissues, leading to many clinical complications, such as neuropathies, tendinopathies, anemia, bone mineral disease and reduced growth in children.
Convective methods might reduce incidence of these complications, by removing molecules of medium-range molecular weight. Online hemodiafiltration (olHDF) is the most extensively used method in this regard. Nevertheless, there are some barriers to the wider introduction of this method in clinical practice, since specific machines are needed for this procedure, the costs with dialysis lines are higher and water consumption increases. More recently, the development of new membranes for hemodialysis allowed removal of medium- and high-range uremic toxins, with albumin retention. Thus, they allow removal of a broad range of uremic toxins, without changing dialysis machine or increasing water consumption. Such therapy is known as expanded hemodialysis (HDx).
The aim of this present study is to compare the extraction of middle-size molecules, the hemodynamic behavior, fluid and nutritional status of patients submitted to olHDF or HDx, in a crossover study.
Conditions
- Dialysis Related Complication
- Dialysis Hypotension
- Hemodialysis-Induced Symptom
Interventions
- DEVICE
-
Expanded Hemodialysis
Intervention: Conversion from conventional HD to expanded hemodialysis por 1 month. High cutoff with high retention onset dialyzers allow clearance of middle molecules, without reducing significantly serum concentration of albumin. It allows higher convective clearance in comparison to conventional hemodialysis, but it is unknown if such clearance is similar to online hemodiafiltration. Therefore, the aim of the present intervention is to compare this dialyzer with online hemodiafiltration
- DEVICE
-
Online Hemodiafiltration
Intervention: Conversion from conventional HD to online Hemodiafiltration por 1 month. Online hemodiafiltration has been associated with lower incidence of intradialytic hypotension in comparison to conventional hemodialysis.
Sponsors & Collaborators
-
University of Sao Paulo
lead OTHER
Principal Investigators
-
Bruno C Silva, PhD · Renal Division, Unversity of São Paulo
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-13
- Primary Completion
- 2018-10-18
- Completion
- 2019-03-11
Countries
- Brazil
Study Locations
More Related Trials
-
Comparison of Post- and Pre-dilutional Hemodiafiltration in Hemodialysis Patients
NCT03288285 ·Status: COMPLETED
-
Hemodiafiltration Versus Hemodialysis in Older People
NCT07278973 ·Status: RECRUITING ·Phase: NA
-
Effects of On-Line Hemodiafiltration(HDF) on Vascular Health in Chronic Hemodialysis Patients
NCT00532597 ·Status: UNKNOWN ·Phase: PHASE4
-
Online Hemodiafiltration vs Conventional Hemodialysis in Acute Kidney Injury
NCT04525092 ·Status: COMPLETED ·Phase: NA
-
Hemodynamic and Respiratory Tolerance of Intermittent Hemodialysis in Critically Ill Patients
NCT04444765 ·Status: COMPLETED
-
Comparing the Hemodiafiltration On-line and Conventional Hemodialysis in Terms of Cost-benefit
NCT02374372 ·Status: COMPLETED ·Phase: NA
-
Impact of Different Dialysis on Sleep Apnea in Patients With Renal Failure
NCT00380848 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Uremic Toxins Clearance With Expanded Hemodialysis
NCT04786535 ·Status: UNKNOWN ·Phase: NA
-
Protein-bound Toxin Removal Between Limited Blood Flow Super High-flux Online HDF and High-Efficiency Online HDF
NCT03288922 ·Status: COMPLETED ·Phase: NA
-
The Effect of On-Line Hemodiafiltration Versus High Flux Hemodialysis on Hemodynamic Parameters in Patients With Intra-Dialytic Hypotension
NCT02719223 ·Status: COMPLETED ·Phase: NA
-
Randomised Study of High-flux Haemodialysis and Haemodiafiltration
NCT01862679 ·Status: COMPLETED ·Phase: NA
-
Effects of pHA Hemoperfusion Plus Hemodialysis on Protein-Bound Uremic Toxins
NCT07016841 ·Status: RECRUITING
-
Combination of Hemodialysis With Hemoperfusion:A Clinical Study
NCT02461953 ·Status: COMPLETED ·Phase: NA
-
The Study of Efficacy and Safety of Automated PD in Urgent Start Dialysis
NCT03754361 ·Status: TERMINATED ·Phase: NA
-
In-Centre Nocturnal Hemodialysis (INHD): A Long-Term Follow-Up Study
NCT02684773 ·Status: COMPLETED
-
Transcapillary Plasma Refill in Advanced Chronic Kidney Disease
NCT03348488 ·Status: COMPLETED ·Phase: NA
-
Ultrafiltration Profiling and Outcomes Among Individuals on Maintenance Hemodialysis
NCT03301740 ·Status: COMPLETED ·Phase: NA
-
RandomizEd ClinicAL triaL on the Efficacy and saFety of Incremental Hemodialysis (REAL-LIFE)
NCT04360694 ·Status: RECRUITING ·Phase: NA
-
Continuous Venovenous Hemofiltration Versus Continuous Venovenuous Hemodialysis
NCT01062984 ·Status: COMPLETED ·Phase: NA
-
Long-term Outcome of End-stage Renal Disease Patients Treated With Hig-efficiency Hemodiafiltration
NCT02576873 ·Status: COMPLETED
-
Interdialytic Peritoneal UltraFiltration in HemoDialysis Patients
NCT04603014 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Clinical Trial Comparing Continuous Versus Intermittent Hemodialysis in ICU Patients
NCT01228123 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Hemodiafiltration Plus MCOs on Uremic Toxins Removal
NCT03938285 ·Status: UNKNOWN ·Phase: NA
-
Long-term, High Blood Flow Hemoadsorption Therapy in Patients Undergoing Maintenance Hemodialysis
NCT06574425 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Mobilising Lower Limb Fluid for Hemodynamic Stability in Haemodialysis
NCT02450474 ·Status: UNKNOWN ·Phase: NA